Literature DB >> 7523867

Polymorphism in the upstream regulatory region and level of expression of HLA-DRB genes.

D P Singal1, X Qiu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523867     DOI: 10.1016/0161-5890(94)90107-4

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


× No keyword cloud information.
  6 in total

1.  HLA-DRB1 gene transcripts in rheumatoid arthritis.

Authors:  S Kerlan-Candon; B Combe; R Vincent; J Clot; V Pinet; J F Eliaou
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  HLA-DR expression and soluble HLA-DR levels in septic patients after trauma.

Authors:  M Ditschkowski; E Kreuzfelder; V Rebmann; S Ferencik; M Majetschak; E N Schmid; U Obertacke; H Hirche; U F Schade; H Grosse-Wilde
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

Review 3.  Regulation of major histocompatibility complex class II gene expression, genetic variation and disease.

Authors:  L Handunnetthi; S V Ramagopalan; G C Ebers; J C Knight
Journal:  Genes Immun       Date:  2009-11-05       Impact factor: 2.676

4.  Polymorphism in both X and Y box motifs controls level of expression of HLA-DRB1 genes.

Authors:  D P Singal; X Qiu
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

5.  HLA-DRB1 may be antagonistically regulated by the coordinately evolved promoter and 3'-UTR under stabilizing selection.

Authors:  Benrong Liu; Yonggui Fu; Zhifen Wang; Sisi Zhou; Yu Sun; Yuping Wu; Anlong Xu
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

6.  Increased TBX6 gene dosages induce congenital cervical vertebral malformations in humans and mice.

Authors:  Xiaojun Ren; Nan Yang; Nan Wu; Jiangang Shi; Feng Zhang; Pengfei Liu; Ximing Xu; Weisheng Chen; Ling Zhang; Yingping Li; Ren-Qian Du; Shuangshuang Dong; Sen Zhao; Shuxia Chen; Li-Ping Jiang; Lianlei Wang; Jianguo Zhang; Zhihong Wu; Li Jin; Guixing Qiu; James R Lupski
Journal:  J Med Genet       Date:  2019-12-30       Impact factor: 5.941

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.